Skip to content

Clinical trials

Neoplasm Metastasis trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Finland Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20061
20072
20092
20101
20115
20122
20144
20151
20161
20181
20191
20202
20211
20221
20231
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated10
Recruiting4
Active, not recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Incyte Corporation3
AbbVie2
Bristol-Myers Squibb2
Eikon Therapeutics2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Pfizer2
Sanofi2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis36
Breast Neoplasms9
Carcinoma, Renal Cell4
Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Transitional Cell3
Endometrial Neoplasms3
Melanoma2
Urinary Bladder Neoplasms2
Acrocephalosyndactylia1

Trials

Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.